Backbone dynamics of oxidised and reduced forms of human atrial natriuretic peptide☆
-
Add time:09/03/2019 Source:sciencedirect.com
The backbone dynamics of the 28 residue 15N-labelled human atrial natriuretic peptide have been examined by 15N NMR methods. 15N R1,R2 and {1H}–15N NOE values were determined for the oxidised and reduced forms of the peptide (ANPox and ANPrd, respectively), and analysed using reduced spectral density mapping and an extended model-free approach. The two forms possessed correlation times for overall molecular motion of 4.7 ns and were highly flexible, with substantial contributions to relaxation processes from internal motions on picosecond to nanosecond time scales. Reduction of the Cys7–Cys23 disulphide bond to form ANPrd produced a very dynamic linear peptide with a mean overall order parameter of 0.2; the intramolecular cross-link in ANPox increased this to a mean value of 0.4. A simple model for segmental backbone motion accounted for the R2 values of both species using only two variable parameters, indicating that relaxation is dominated by interactions with sites <7 residues distant in the covalent network and that changes in the conformation of the disulphide bond lead to significant chemical exchange broadening in ANPox. The contributions of backbone dynamics to configurational entropy were determined and accounted for the different receptor binding affinities of cyclised and linear natriuretic peptides.
We also recommend Trading Suppliers and Manufacturers of atrial natriuretic factor (7-23)amide (cas 114191-94-5). Pls Click Website Link as below: cas 114191-94-5 suppliers
Prev:Development of more potent atrial natriuretic factor (ANF) analogs
Next:Atrial natriuretic polypeptides: Structure-activity relationship in the central action — a comparison of their antidipsogenic actions) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Atrial natriuretic polypeptides: Structure-activity relationship in the central action — a comparison of their antidipsogenic actions09/04/2019
- Development of more potent atrial natriuretic factor (ANF) analogs09/02/2019
- Release of atrial natriuretic factor induced by the A1 adenosine receptor agonist 2-chloro-N6-cyclopentyl-adenosine in the rat09/01/2019
- Atrial natriuretic peptide increases adrenomedullin in the circulation of healthy humans08/31/2019
- Basic—Liver, Pancreas, and Biliary TractAtrial Natriuretic Factor Stimulates Efflux of cAMP in Rat Exocrine Pancreas via Multidrug Resistance–Associated Proteins08/30/2019
- Atrial natriuretic factor stimulates renal dopamine uptake mediated by natriuretic peptide-type A receptor08/29/2019
- Atrial natriuretic factor intracellular signaling in the rat submandibular gland08/28/2019


